Annual report
2269.TEDINET S100YILP
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.17T | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥1.15T | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.11T | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.06T | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.01T | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥93.3bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥84.7bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥96.6bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥82.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥76.0bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥74.2bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥94.0bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥68.0bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥82.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥35.1bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥50.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥50.7bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥69.4bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥87.5bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥38.8bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥54.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥1.26T | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥1.18T | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.21T | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.14T | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.12T | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥444.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥392.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥817.6bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥791.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥787.8bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥751.3bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥713.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥69.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥78.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥49.6bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥66.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥102.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.9bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥64.9bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥56.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥69.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥108.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥85.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥127.5bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥110.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥40.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥24.6bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥36.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27.6bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥34.6bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥61.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥43.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥54.7bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥77.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥129.42 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.08 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.64 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.39 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥303.62 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,849.8 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,762.33 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,674.72 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,553.69 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,390.76 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 61.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.9% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.6% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.0% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.5% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 17,103 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 17,231 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 17,270 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 17,290 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 17,336 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥36.3bn | 2025-04-01 → 2026-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥48.7bn | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥30.6bn | 2023-04-01 → 2024-03-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥28.1bn | 2022-04-01 → 2023-03-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥34.5bn | 2021-04-01 → 2022-03-31v | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥24.6bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥38.7bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥24.8bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥39.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥24.9bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23.9bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥31.1bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥24.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥42.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥25.4bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥42.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥32.9bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥28.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥31.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥415.9bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥349.8bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥364.8bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥369.2bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥391.4bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥196.1bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥124.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥219.9bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥225.6bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥244.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥238.4bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥246.0bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥93.64 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥155.94 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.79 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.97 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.12 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥105 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥95 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥170 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥810.96 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥832.92 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥874.99 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥855.11 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥873.6 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 52.9% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.5% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.0% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.6% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 282,200,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 282,200,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 293,459,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 148,369,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 148,369,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 298 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 295 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 116 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 99 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 85 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥676m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥399m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | −¥44.6bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥5.9bn |
| Foodreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥61.2bn |
| Foodreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥44.0bn |
| Foodreportable segment | employees | at 2026-03-31 | 9845 pure |
| Foodreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥942.9bn |
| Foodreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥941.5bn |
| Foodreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Foodreportable segment | segment assets | at 2026-03-31 | ¥870.5bn |
| Foodreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥68.7bn |
| Pharmaceuticalsreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥28.2bn |
| Pharmaceuticalsreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥10.5bn |
| Pharmaceuticalsreportable segment | employees | at 2026-03-31 | 6953 pure |
| Pharmaceuticalsreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥232.2bn |
| Pharmaceuticalsreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥232.2bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥26m |
| Pharmaceuticalsreportable segment | segment assets | at 2026-03-31 | ¥435.9bn |
| Pharmaceuticalsreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥30.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥89.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥54.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥1.18T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥1.17T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥1.31T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥99.2bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥641m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥370m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | −¥39.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥4.7bn |
| Foodreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥36.6bn |
| Foodreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥44.9bn |
| Foodreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥925.6bn |
| Foodreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥924.4bn |
| Foodreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Foodreportable segment | segment assets | at 2025-03-31 | ¥835.3bn |
| Foodreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥64.6bn |
| Pharmaceuticalsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥17.3bn |
| Pharmaceuticalsreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥9.7bn |
| Pharmaceuticalsreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥229.7bn |
| Pharmaceuticalsreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥229.6bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥20m |
| Pharmaceuticalsreportable segment | segment assets | at 2025-03-31 | ¥388.3bn |
| Pharmaceuticalsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥53.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥54.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥1.16T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥1.15T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥1.22T |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥89.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,891
| Item | Context | Value | Unit |
|---|---|---|---|
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row8Member | Original text (Japanese)食品セグメントにおける仕入先であり、取引関係の強化のため保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row8Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row9Member | Original text (Japanese)ユナイテッド・スーパーマーケット・ホールディングス(株) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row9Member | Original text (Japanese)食品セグメントにおける販売先であり、取引関係の強化のため保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row9Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row10Member | Original text (Japanese)(株)ライフコーポレーション | |
| Number of shares not disclosed as below threshold details of specified investment shares held for purposes other than pure investment second largest holding company | Prior1YearInstant_Row10Member | * | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row10Member | Original text (Japanese)食品セグメントにおける販売先であり、取引関係の強化のため保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row10Member | Original text (Japanese)無 | |
| Carrying amount not disclosed as below threshold details of specified investment shares held for purposes other than pure investment second largest holding company | Prior1YearInstant_Row10Member | * | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row11Member | Original text (Japanese)三菱食品(株) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row11Member | Original text (Japanese)同社株式は2026年３月31日現在で保有しておりません。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row11Member | Original text (Japanese)無 | |
| Footnotes specified investment shares held for purposes other than pure investment second largest holding company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Footnotes specified investment shares held for purposes other than pure investment second largest holding company (text) | CurrentYearInstant_Row2Member | Text · Plus | |
| Name of securities details of deemed holdings of equity securities held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)(株)みずほフィナンシャルグループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of deemed holdings of shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)議決権行使に関する指図権を有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of deemed holdings of shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of deemed holdings of equity securities held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)(株)三菱ＵＦＪフィナンシャル・グループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of deemed holdings of shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)議決権行使に関する指図権を有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of deemed holdings of shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of deemed holdings of equity securities held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)三井住友トラストグループ(株) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of deemed holdings of shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)議決権行使に関する指図権を有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of deemed holdings of shares held for purposes other than pure investment second largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)無 | |
| Footnotes deemed holdings of shares held for purposes other than pure investment second largest holding company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Basic policy on human resources strategy employees etc (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)㈱明治 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | Original text (Japanese)Meiji Seika ファルマ㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | Original text (Japanese)ＫＭバイオロジクス㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | Original text (Japanese)明治フレッシュネットワーク㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | Original text (Japanese)四国明治㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | Original text (Japanese)明治ロジテック㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row7Member | Original text (Japanese)群馬明治㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row8Member | Original text (Japanese)明治チューインガム㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row9Member | Original text (Japanese)道南食品㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row10Member | Original text (Japanese)東海ナッツ㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row11Member | Original text (Japanese)明治アドエージェンシー㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row12Member | Original text (Japanese)明治飼糧㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row13Member | Original text (Japanese)日本罐詰㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row14Member | Original text (Japanese)栃木明治牛乳㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row15Member | Original text (Japanese)大蔵製薬㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row16Member | Original text (Japanese)Meiji Seika ファルマテック㈱ | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |